Weishi Li is a partner in the firm's Life Sciences Transactions Practice. Her practice focuses on transactional matters for life sciences clients. She has extensive experience assisting Western and Chinese life sciences companies in structuring and negotiating cross-border commercial, corporate, and partnering transactions involving China, including strategic collaborations, joint ventures, licensing, acquisitions, co-promotion, and distribution arrangements. As a registered U.S. patent attorney with a Ph.D. in microbiology and substantial food and drug regulatory experience, Weishi has a deep understanding of the complex issues confronting the industry and is well-versed in helping clients tackling such issues.